The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
The study also showed a clear dose-dependent trend, with the 75 mg QD group outperforming the 50 mg QD cohort
Expands bioprocessing footprint across Asia
Presbyopia, the age-related loss of near vision, could soon be treated successfully
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Moraine will serve as OTSAW’s exclusive distributor in Japan, deploying the Camello+ autonomous mobile robot and TransCar autonomous guided vehicle to support hospital logistics
Subscribe To Our Newsletter & Stay Updated
